NCT05813015View on ClinicalTrials.gov

Study of Comparing of With and Without Sequential Therapy of S-1

PHASE3RecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 28, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Locally Advanced Gastric AdenocarcinomaChemotherapy Effect
Interventions
DRUG

Docetaxel

Docetaxel 40mg/m2，every 21 days，6 cycles.

DRUG

Tegafur-Gimeracil-Oteracil

S-1 40-60mg/m2，p.o, BID, day 1-14, till 1 year postoperation.

Trial Locations (1)

310000

RECRUITING

Gastrointestinal Department of Second Affiliated Hospital of Zhejiang University, Hanzhou

All Listed Sponsors
lead

Zhejiang University

OTHER